Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker VIR
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 9, 2026 | VIR Vir Biotechnology, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 9, 2026 | VIR Vir Biotechnology, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 4, 2026 | VIR Vir Biotechnology, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 28, 2026 | VIR Vir Biotechnology, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Oct 14, 2026 | VIR Vir Biotechnology, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 14, 2026 | VIR Vir Biotechnology, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Oct 8, 2026 | VIR Vir Biotechnology, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 1, 2026 | VIR Vir Biotechnology, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 1, 2026 | VIR Vir Biotechnology, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Aug 5, 2026 | VIR Vir Biotechnology, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 24, 2026 | VIR Vir Biotechnology, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Jun 10, 2026 | VIR Vir Biotechnology, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 28, 2026 | VIR Vir Biotechnology, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 28, 2026 | VIR Vir Biotechnology, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 6, 2026 | VIR Vir Biotechnology, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 10, 2026 | VIR Vir Biotechnology, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Mar 4, 2026 | VIR Vir Biotechnology, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Mar 2, 2026 | VIR Vir Biotechnology, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Feb 26, 2026 | VIR Vir Biotechnology, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Feb 23, 2026 | VIR Vir Biotechnology, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Feb 23, 2026 | VIR Vir Biotechnology, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Feb 23, 2026 | VIR Vir Biotechnology, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 23, 2026 | VIR Vir Biotechnology, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jan 12, 2026 | VIR Vir Biotechnology, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 12, 2026 | VIR Vir Biotechnology, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 16, 2025 | VIR Vir Biotechnology, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 16, 2025 | VIR Vir Biotechnology, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Nov 5, 2025 | VIR Vir Biotechnology, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 6, 2025 | VIR Vir Biotechnology, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 24, 2025 | VIR Vir Biotechnology, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| May 29, 2025 | VIR Vir Biotechnology, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 9, 2025 | VIR Vir Biotechnology, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| May 7, 2025 | VIR Vir Biotechnology, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 26, 2025 | VIR Vir Biotechnology, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 30, 2025 | VIR Vir Biotechnology, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Jan 8, 2025 | VIR Vir Biotechnology, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 8, 2025 | VIR Vir Biotechnology, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 31, 2024 | VIR Vir Biotechnology, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
38 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:12 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances